Published in BMJ on June 15, 2010
Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med (2011) 1.83
Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC Biol (2010) 1.83
Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq. J Clin Microbiol (2011) 1.33
Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size. BMC Public Health (2011) 1.22
Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis. PLoS Med (2012) 1.16
The impact of new vaccine introduction on immunization and health systems: a review of the published literature. Vaccine (2012) 1.12
Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial. Vaccine (2012) 1.09
Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS One (2012) 1.05
Rotavirus vaccines: current status and future considerations. Hum Vaccin Immunother (2014) 1.02
Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA. Vaccine (2010) 0.98
Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study. BMJ (2013) 0.97
Etiology of childhood diarrhea after rotavirus vaccine introduction: a prospective, population-based study in Nicaragua. Pediatr Infect Dis J (2014) 0.94
Rotavirus vaccines: update on global impact and future priorities. Hum Vaccin (2011) 0.92
Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcome. Hum Vaccin Immunother (2013) 0.90
Genetic diversity of circulating rotavirus strains in Tanzania prior to the introduction of vaccination. PLoS One (2014) 0.89
Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models. PLoS One (2012) 0.87
Co-expression of anti-rotavirus proteins (llama VHH antibody fragments) in Lactobacillus: development and functionality of vectors containing two expression cassettes in tandem. PLoS One (2014) 0.86
Rotavirus gastroenteritis in children under 5 years in the Kingdom of Bahrain: hospital-based surveillance. Clin Epidemiol (2013) 0.83
Catching-up with pentavalent vaccine: Exploring reasons behind lower rotavirus vaccine coverage in El Salvador. Vaccine (2015) 0.80
Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial. J Infect Dis (2016) 0.79
Overcoming perceptions of financial barriers to rotavirus vaccine introduction in Asia. Hum Vaccin Immunother (2013) 0.78
Potential for use of retinoic acid as an oral vaccine adjuvant. Philos Trans R Soc Lond B Biol Sci (2015) 0.78
Mutation distribution in the NSP4 protein in rotaviruses isolated from Mexican children with moderate to severe gastroenteritis. Viruses (2013) 0.77
Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysis. Infect Dis Poverty (2016) 0.75
Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean. BMC Pediatr (2017) 0.75
Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: randomized, double-blind, placebo-controlled Phase I studies. Hum Vaccin Immunother (2013) 0.75
A sham case-control study of effectiveness of DTP-Hib-hepatitis B vaccine against rotavirus acute gastroenteritis in Kenya. BMC Infect Dis (2014) 0.75
Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial. PLoS Med (2017) 0.75
Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies. BMC Infect Dis (2017) 0.75
Spatial and temporal patterns of diarrhoea in Bhutan 2003-2013. BMC Infect Dis (2017) 0.75
Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med (2006) 11.49
Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol (1990) 10.23
Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med (2006) 9.93
Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol (1992) 8.25
Rotavirus and severe childhood diarrhea. Emerg Infect Dis (2006) 7.80
Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med (2010) 6.56
Field evaluation of vaccine efficacy. Bull World Health Organ (1985) 4.95
Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet (2007) 4.45
Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis (1990) 4.42
Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med (1997) 3.80
Global mortality associated with rotavirus disease among children in 2004. J Infect Dis (2009) 3.63
Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol (1994) 3.50
Rotavirus vaccines: current prospects and future challenges. Lancet (2006) 2.97
Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet (1986) 2.29
Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA (2009) 2.16
Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis (2009) 2.12
Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J Pediatr (1997) 2.07
Meeting of the immunization Strategic Advisory Group of Experts, April 2009--conclusions and recommendations. Wkly Epidemiol Rec (2009) 2.06
Rotavirus vaccines. Wkly Epidemiol Rec (2007) 1.89
Characterization of nontypeable rotavirus strains from the United States: identification of a new rotavirus reassortant (P2A[6],G12) and rare P3[9] strains related to bovine rotaviruses. Virology (2002) 1.85
Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics (2009) 1.84
Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group. JAMA (1995) 1.58
Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis (2010) 1.51
Enteric infections and the vaccines to counter them: future directions. Vaccine (2006) 1.45
Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR. J Infect Dis (1999) 1.35
Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil. Bull World Health Organ (1996) 1.22
Rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis (2008) 1.07
Update on rotavirus vaccines. Pediatr Infect Dis J (2005) 1.06
Burden of disease and circulating serotypes of rotavirus infection in sub-Saharan Africa: systematic review and meta-analysis. Lancet Infect Dis (2009) 1.04
The protective effectiveness of natural rotavirus infection in an American Indian population. J Infect Dis (1998) 1.02
A developing country perspective on vaccine-associated paralytic poliomyelitis. Bull World Health Organ (2004) 0.99
Rotavirus in El Salvador: an outbreak, surveillance and estimates of disease burden, 2000-2002. Pediatr Infect Dis J (2004) 0.83
Sample size determination for pair-matched case-control studies where the goal is interval estimation of the odds ratio. J Clin Epidemiol (1990) 0.82
Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med (2011) 4.49
Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology (2002) 3.79
GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med (2013) 3.37
Recent resurgence of mumps in the United States. N Engl J Med (2008) 2.90
Ricin poisoning: a comprehensive review. JAMA (2005) 2.62
The future of rotavirus vaccines: a major setback leads to new opportunities. Lancet (2004) 2.43
Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med (2010) 2.26
Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA (2009) 2.16
Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr (2008) 2.00
Fine needle aspiration of a neck lump: a mercurial mystery. Br J Oral Maxillofac Surg (2009) 1.93
Workgroup report: public health strategies for reducing aflatoxin exposure in developing countries. Environ Health Perspect (2006) 1.89
Rotavirus antigenemia in patients with acute gastroenteritis. J Infect Dis (2005) 1.89
A high utility integrated map of the pig genome. Genome Biol (2007) 1.88
Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med (2011) 1.83
Early detection of illness associated with poisonings of public health significance. Ann Emerg Med (2005) 1.80
Acute muscular sarcocystosis: an international investigation among ill travelers returning from Tioman Island, Malaysia, 2011-2012. Clin Infect Dis (2014) 1.80
Rotavirus vaccines: successes and challenges. J Infect (2013) 1.74
Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerg Infect Dis (2005) 1.74
Robotic-assisted nephroureterectomy and bladder cuff excision without intraoperative repositioning. Urology (2011) 1.64
Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J (2011) 1.63
Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics (2008) 1.63
The complete genome sequence of Roseobacter denitrificans reveals a mixotrophic rather than photosynthetic metabolism. J Bacteriol (2006) 1.61
Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial. Infect Control Hosp Epidemiol (2009) 1.60
Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003. J Infect Dis (2007) 1.51
Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr Infect Dis J (2010) 1.48
Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma. J Pediatr (2013) 1.48
Surveillance for travel-related disease--GeoSentinel Surveillance System, United States, 1997-2011. MMWR Surveill Summ (2013) 1.46
Local and International Implications of Schistosomiasis Acquired in Corsica, France. Emerg Infect Dis (2015) 1.45
Foundations of the severe acute respiratory syndrome preparedness and response plan for healthcare facilities. Infect Control Hosp Epidemiol (2004) 1.42
Disassembly of a rotablator: getting out of a trap. Catheter Cardiovasc Interv (2003) 1.42
Enhancement of detection and quantification of rotavirus in stool using a modified real-time RT-PCR assay. J Med Virol (2008) 1.41
Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J (2011) 1.41
The efficacy, safety and tolerability of intracavernous PNU-83757 for the treatment of erectile dysfunction. J Urol (2002) 1.39
Performance of rotavirus vaccines in developed and developing countries. Hum Vaccin (2010) 1.39
FlyExpress: visual mining of spatiotemporal patterns for genes and publications in Drosophila embryogenesis. Bioinformatics (2011) 1.33
Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030. Vaccine (2012) 1.31
Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya. J Infect Dis (2009) 1.29
Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J (2011) 1.28
ATAQS: A computational software tool for high throughput transition optimization and validation for selected reaction monitoring mass spectrometry. BMC Bioinformatics (2011) 1.28
Serologically confirmed household transmission of 2009 pandemic influenza A (H1N1) virus during the first pandemic wave--New York City, April-May 2009. Clin Infect Dis (2011) 1.22
Prestin-based outer hair cell electromotility in knockin mice does not appear to adjust the operating point of a cilia-based amplifier. Proc Natl Acad Sci U S A (2007) 1.20
Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries. Pediatr Infect Dis J (2013) 1.17
Epidemiologic implications of asymptomatic reinfection: a mathematical modeling study of norovirus. Am J Epidemiol (2013) 1.17
Global seasonality of rotavirus disease. Pediatr Infect Dis J (2013) 1.17
Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis. PLoS Med (2012) 1.16
Sentinel hospital surveillance for rotavirus in latin american and Caribbean countries. J Infect Dis (2009) 1.16
Hospitalizations and mortality associated with norovirus outbreaks in nursing homes, 2009-2010. JAMA (2012) 1.16
Oncogenic action of phospholipase A2 in prostate cancer. Cancer Lett (2005) 1.14
Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines. J Infect Dis (2009) 1.14
Childhood intussusception: a literature review. PLoS One (2013) 1.13
Assessment of the epidemic potential of a new strain of rotavirus associated with the novel G9 serotype which caused an outbreak in the United States for the first time in the 1995-1996 season. J Clin Microbiol (2004) 1.13
A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. J Infect Dis (2013) 1.12
Molecular epidemiological profile of rotavirus in South Korea, July 2002 through June 2003: emergence of G4P[6] and G9P[8] strains. J Infect Dis (2005) 1.11
Adsorption of As(V) and As(III) by nanocrystalline titanium dioxide. Water Res (2005) 1.09
Disease and economic burden of rotavirus diarrhoea in India. Vaccine (2009) 1.09
Transcriptional repressor E4-binding protein 4 (E4BP4) regulates metabolic hormone fibroblast growth factor 21 (FGF21) during circadian cycles and feeding. J Biol Chem (2010) 1.08
Diagnostic accuracy of hospitalist-performed hand-carried ultrasound echocardiography after a brief training program. J Hosp Med (2009) 1.07
Rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis (2008) 1.07
The Toxic Exposure Surveillance System (TESS): risk assessment and real-time toxicovigilance across United States poison centers. Toxicol Appl Pharmacol (2005) 1.07
Prolonged Venovenous Extracorporeal Membrane Oxygenation in a Patient With Acute Respiratory Distress Syndrome. ASAIO J (2016) 1.07
Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel Surveillance Network. Ann Intern Med (2015) 1.06
Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma. Arch Surg (2002) 1.06
Incidence of severe rotavirus diarrhea in New Delhi, India, and G and P types of the infecting rotavirus strains. J Infect Dis (2005) 1.06
Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial. Vaccine (2006) 1.05
Fluorescent fructose derivatives for imaging breast cancer cells. Bioconjug Chem (2007) 1.05
Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA (2012) 1.05
Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS One (2012) 1.05
Bilateral cavernous nerve interposition grafting during radical retropubic prostatectomy: Memorial Sloan-Kettering Cancer Center experience. J Urol (2007) 1.04
Rotavirus strain surveillance in Latin America: a review of the last nine years. Pediatr Infect Dis J (2004) 1.04
Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000-2003: PROTEKT US years 1-3. J Infect (2005) 1.02
Epidemiological profile of rotavirus infection in the Republic of Korea: results from prospective surveillance in the Jeongeub District, 1 July 2002 through 30 June 2004. J Infect Dis (2005) 1.02
Autism spectrum disorder: interaction of air pollution with the MET receptor tyrosine kinase gene. Epidemiology (2014) 1.02
Profile of illness in Syrian refugees: A GeoSentinel analysis, 2013 to 2015. Euro Surveill (2016) 1.02
Bioterrorism-related inhalational anthrax in an elderly woman, Connecticut, 2001. Emerg Infect Dis (2003) 1.02
TGF-beta 1 inhibits mast cell Fc epsilon RI expression. J Immunol (2005) 1.00
Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene. J Nucl Med (2006) 0.99
Removal of arsenic from groundwater by granular titanium dioxide adsorbent. Chemosphere (2005) 0.99
Risk factors for diarrhea-associated infant mortality in the United States, 2005-2007. Pediatr Infect Dis J (2012) 0.98
Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study. BMJ (2013) 0.97
Norovirus detection and genotyping for children with gastroenteritis, Brazil. Emerg Infect Dis (2007) 0.97
Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia. J Antimicrob Chemother (2004) 0.97
Importance and challenges of accurately counting rotavirus deaths in China, 2002. Vaccine (2009) 0.96
Quantitative evaluation of rotaviral antigenemia in children with acute rotaviral diarrhea. J Infect Dis (2006) 0.96
Rotavirus disease burden among children <5 years of age--Santa Rosa, Guatemala, 2007-2009. Trop Med Int Health (2011) 0.95
Rotavirus and rotavirus vaccines. Adv Exp Med Biol (2006) 0.95